shr2150
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Oct 10, 2020 (NCT04588324)
Timeline
2020s
- Jan 1, 2020
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Toll-like receptor 7AGONIST
TLR7 agonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05141422 | Phase 1 | Dec 15, 2021 | Hengrui Therapeutics, Inc. |
| NCT04588324 | Phase 1/Phase 2 (Phase 2) | Oct 10, 2020 | People's Liberation Army of China |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Hengrui Therapeutics, Inc. | For profit | 1 | 1 | 1 | 2021 |
| People's Liberation Army of China | Government | 1 | 1 | 1 | 2020 |
2 organizations
Page 1 / 1